Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

11.80
Delayed Data
As of Nov 21
 -0.05 / -0.42%
Today’s Change
5.40
Today|||52-Week Range
12.35
+80.15%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close11.85
Today’s open11.80
Day’s range11.75 - 11.85
Volume181,450
Average volume (3 months)132,664
Market cap$277.6M
Dividend yield--
Data as of 3:59pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-143.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-5.35%
P/E ratioNM
Price/Sales3.12
Price/Book1.98

Competitors

 Today’s
change
Today’s
% change
VYGRVoyager Therapeutics...+0.02+0.14%
TOCATocagen Inc-0.18-1.77%
PTGXProtagonist Therapeu...+0.53+2.86%
PIRSPieris Pharmaceutica...+0.11+1.77%
Data as of 4:00pm ET, 11/21/2017

Financials

Last reporting dateNovember 22, 2017
EPS forecast (this quarter)$0.10
Annual revenue (last year)$47.7M
Annual profit (last year)-$2.9M
Net profit margin-6.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Erez Israeli
Chief Operating Officer &
Vice President
Efrat Manoff
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts